Oncotelic Therapeutics, Inc. 8-K

What Happened
On July 14, 2026, Oncotelic Therapeutics, Inc. filed a Form 8‑K reporting that on July 13, 2026 the company presented a corporate presentation to its employees, directors, officers and advisors. A copy of that Corporate Presentation is included as Exhibit 99.1 to the Form 8‑K. The filing notes the materials are being furnished and not “filed” for purposes of Section 18 of the Exchange Act and are not incorporated by reference into other filings except by specific reference.

Key Details

• Presentation date: July 13, 2026; Form 8‑K filed July 14, 2026.
• Audience: employees, directors, officers and advisors.
• Exhibit attached: Exhibit 99.1 (Corporate Presentation); interactive XBRL cover page also included.
• Filing status: materials are furnished (disclaimer that they are not “filed” under the Exchange Act).

Why It Matters
This 8‑K notifies investors that the company has shared a corporate presentation internally and with advisors; the attached slide deck may include strategic or operational updates useful to shareholders. Because the presentation is furnished (not formally “filed”), the company limits the legal effect of the disclosure under SEC rules. Investors who want details should review Exhibit 99.1 in the 8‑K to see any specific updates; the filing does not report earnings, executive changes, material agreements, or financial results.